Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the EU approval of mNexspike ...

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) vaccine, Arexvy, for all adults above the age of 18, paving the way for broader ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Moderna Inc. fell Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market. Vinay Prasad, a top FDA official, blamed ...

Research led by the Veterans Affairs Portland Health Care System in Portland, Oregon, found that a single dose of respiratory syncytial virus (RSV) vaccine reduced RSV infections and RSV-related ...